Park Soon-jae
$3.0B
Born
Dec 22, 1954
Age
70
Source of Wealth
Biopharmaceuticals
Residence
Daejeon,
Citizenship
South Korea
Marital Status
Married
Children
0
Education
Ph.D, Purdue University
- Park Soon-jae is cofounder and CEO of South Korean biotechnology company Alteogen, which focuses on biosimilars and bio-betters.
- Alteogen is wildely known for its ALT-B4, an enzyme with technology that allows drugs to be administered subcutaneously instead of intravenously.
- In 2024, Alteogen revealed Merck had agreed to a licensing deal to use ALT-B4 for the drug giant's cancer drug pembrolizumab. Alteogen shares soared 25% in a day following the announcement.
- Park's wife, Chung Hye-shin, who is chief scientific officer of Alteogen, owns a small stake in the company.
- Prior to cofounding Alteogen in 2008, Park worked at LG Life Sciences and Hanwha Petrochemical, and was a postdoctoral researcher at MIT.
| Exchange | Ticker | Company Name | Number Of Shares | Share Price | Currency Code |
|---|